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Ethnopharmacological relevance: T. diversifolia (Hemsl.) A. Gray (Asteraceae) has been used in the tradi-
tional medicine in several countries as anti-inﬂammatory and against other illnesses. It is important to
evaluate the anti-inﬂammatory activity of extracts from the leaves of this species, including an infu-
sion, to identify the main constituents of the extracts, observe their effects and correlate them with the
anti-inﬂammatory activity.
Materials and methods: An infusion, a leaf rinse extract (LRE) and a polar extract from the rinsed leaves
(PE) were obtained and analysed by HPLC-UV-DAD and infrared spectroscopy. The major compounds of
these extracts were quantiﬁed. The three obtained extracts were evaluated for their anti-inﬂammatory
activities using the paw oedema and croton oil ear oedema assays in mice. Furthermore, neutrophil
migration was measured by evaluating myeloperoxidase activity.
Results: The PE consists primarily of chlorogenic acids (CAs) and lacks sesquiterpene lactones (STLs). The
LRE is rich in STLs and includes a few ﬂavonoids. The infusion is chemically similar to the PE but also
contains very low amounts of STLs. The PE and LRE have better mechanisms of action than non-steroidal
anti-inﬂammatory drugs (NSAIDs). Unlike NSAIDs, both the PE and LRE inhibit oedema and neutrophil
migration. The pool of CAs from the PE of T. diversifolia has an additional mechanism of action, and its
anti-inﬂammatory effect was greater than what is described in the literature for this class of compounds
using the same evaluation models. The similar chemical compositions observed for the infusion and the
PE, contrasted with the different activities observed, suggests the presence of antagonist compounds
produced during the extraction procedure (infusion); the infusion did not inhibit oedema, however it
inhibited neutrophil migration. It suggests that although the great majority of plants present CAs, the
category of anti-inﬂammatory effect of their extracts depends on a suitable pool of compounds and an
absence of antagonists, among other factors.
Conclusions: CAs from T. diversifolia comprise a good pool of anti-inﬂammatory compounds with better
activity mechanisms than NSAIDs, other active compounds from the leaf extracts (STLs and ﬂavonoids)
and CAs from other plant sources. Thus, the PE of T. diversifolia has high potential for the development
of new anti-inﬂammatory phytomedicines. The infusion probably contains antagonists, and therefore it
can be useful to treat inﬂammation processes where neutrophil recruitment is involved and oedema is
not.
 ∗ Corresponding author. Tel.: +55 16 3602 0661; fax: +55 16 3602 4879.
E-mail address: febcosta@fcfrp.usp.br (F.B. Da Costa).
378-8741 © 2011 Elsevier Ireland Ltd. 
oi:10.1016/j.jep.2011.04.067
Open access under the Elsevier OA license. © 2011 Elsevier Ireland Ltd. 
1. Introduction
Tithonia diversifolia (Hemsl.) A. Gray (Asteraceae) is native to the
Open access under the Elsevier OA license.lowlands of Southeastern Mexico and Central America (La Duke,
1982). Nowadays, it is spread all over the world; it is found in
Central and South America as well as in Asia, Africa and Australia
(Ambrosio et al., 2008). T. diversifolia has been exhaustively studied
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nd possesses several biological activities including the following:
nti-inﬂammatory, analgesic, antimalarial, antiviral, antidiabetic,
ntidiarrhoeal and antimicrobial, among others (Cos et al., 2002;
woyele et al., 2004; Kuroda et al., 2007). Besides these numer-
us, documented biological activities, this plant is important due
o its substantial use within traditional medicine in several coun-
ries (Frei et al., 1998; Heinrich et al., 1998; Játem-Lásser et al.,
998).
The biological activities presented by T. diversifolia have been
ttributed to the presence of sesquiterpene lactones (STLs) because
hese compounds occur in large amounts (>2% dry weight of
eaves) in Asteraceae and comprise an important class of secondary
etabolites responsible for several pharmacological or toxic activi-
ies (Heinrich et al., 1998). The investigated active compounds from
. diversifolia extracts are almost exclusively STLs, but include a few
avonoids and the diterpene kaurenoic acid. Polar extracts have
lso displayed biological activities (Cos et al., 2002; Owoyele et al.,
004), but their chemical compositionshavenot yet been studied in
etail. In summary, althoughmany pharmacological activities have
een reported for compounds isolated from T. diversifolia, there is
till a lack of extract standardization and high-quality phytochem-
cal studies.
The oedema and cell recruitment are important effects in the
nﬂammatory process. There are animal models that can be used to
valuate anti-oedematogenic effect and inhibition of cell recruit-
ent. The carrageenan-induced paw oedema and croton oil ear
edema are good models that can evaluate both effects and are
uitable for p.o. and topical evaluations, respectively (Winter et al.,
962; Tubaro et al., 1985). These models are well known and sev-
ral inﬂammatory mediators are involved in the oedematogenic
ffect; nevertheless, oedema is principally related to the release of
rostaglandin via cyclooxygenase (COX), an enzyme that is inhib-
ted by non-steroidal anti-inﬂammatory drugs (NSAIDs) (Di Rosa,
972; Sánchez and Moreno, 1999; Wang et al., 2001; Ueno and
h-ishi, 2002). Cell recruitment cannot be inhibited by common
nti-inﬂammatory drugs; thus, the NSAIDs have limited effect in
ome categories of inﬂammatory processes and present some side
ffects, as gastric damage (Ferreira and Vane, 1974; Parente, 2001).
herefore it is important to ﬁnd anti-oedematogenic treatments
hat can also inhibit cell recruitment (Witko-Sarsat et al., 2000;
arente, 2001; Venkatesha et al., 2011).
Considering the possibility that polar compounds display anti-
nﬂammatory activities without the side effects associated with
TLs, the main aim of the present study was to evaluate the anti-
nﬂammatory activity of three different extracts from the leaves
f T. diversifolia when administered orally or topically in suitable
nimal models. Of the three extracts described, one is rich in STLs,
nother is rich in polar compounds, and the third is an infusion.
e also propose to obtain the chemical proﬁle of all extracts by
PLC-UV-DAD to identify the main chemical constituents as well
s to quantify the major compounds. Finally, we propose to cor-
elate the observed biological activities with the main metabolite
roups present in each extract.
. Materials and methods
.1. Plant material
Leaves from T. diversifolia were collected by D.A. Chagas-Paula
n March, 2008, in Ribeirão Preto, SP, Brazil (S 21◦ 10.681′; W
47◦ 51.541′; altitude 538m). A voucher specimen (R.B. Oliveira
97) was deposited in the herbarium SPFR of the Departmento de
iologia, FFCLRP, USP, Ribeirão Preto, SP, Brazil. Whole leaves were
ir-dried at 40 ◦C for a week and kept in humidity and light-free
onditions until the extraction process was initiated.pharmacology 136 (2011) 355–362
2.2. Extract preparation
2.2.1. Leaf rinse extract (LRE)
The LRE was obtained from 40g of whole, dried leaves individu-
ally rinsed for 20min with 500ml of acetone. The obtained extract
was ﬁltered through common ﬁlter paper, and after solvent evap-
oration under reduced pressure, the dry residue was re-suspended
in 10ml of MeOH/H2O (7:3, v/v) to precipitate lipophilic material.
The precipitate was discarded, and the solvent from the super-
natant was evaporated under reduced pressure. After evaporation,
the supernatant was lyophilized and kept at −20 ◦C until use. This
procedure promotes preferential extraction of compounds stored
in glandular trichomes on the abaxial leaf surface. As the main con-
stituents of such trichomes are STLs (Ambrosio et al., 2008), the
obtained extract (453mg) was presumed to be very rich in this
class of compounds.
2.2.2. Polar extract (PE)
The polar extract (PE) was prepared using 8g of dried leaves
previously rinsed with acetone (see above) that were further mac-
erated at room temperature with MeOH/H2O (7:3, v/v) for three
days; the solvent (40ml) was changed every 24h. The obtained
extract was ﬁltered through common ﬁlter paper and further par-
titioned three times with n-hexane. The hydromethanolic fraction
had the solvent evaporated under reduced pressure, and was then
lyophilized and kept at −20 ◦C until use. Using leaves previously
rinsedwithacetone, the extract (1.0 g)wasexpected tobeverypoor
in STLs, or lack them completely, and very rich in polar compounds.
2.2.3. Infusion
The infusion was prepared from 8g of powdered dried leaves
mixed ina cappedcontainerwithboilingdistilledwater (1:10,w/v),
for 20min. After ﬁltration through common ﬁlter paper, the infu-
sion was lyophilized and yielded 544.4mg of crude material. The
material was stored at −20 ◦C until use.
2.3. Phytochemical analysis and quantiﬁcation of the major
compounds
The three extracts were analysed by infrared (IR) spectroscopy
and HPLC-UV-DAD. The IR measurements were carried out in
a Perkin Elmer RX-ISTIR System spectrometer, and the samples
were analysed in discs of KBr. The identiﬁcation of the main con-
stituents was based on UV data and comparison of their retention
times in HPLC with authentic standards available in the labora-
tory (Ambrosio et al., 2008; Gobbo-Neto and Lopes, 2008). The
HPLC-UV-DAD proﬁling of the three extracts was performed on a
Shimadzu liquid chromatograph (LC-10 Avp pumps, SCL-10 Avp
controller, SPD-10 Avp diode array detector – DAD, and software
Class VP, version 5.02) using two C-18 Onix monolithic columns
(3mm×100mm; Phenomenex) coupled in series, with a ﬂow
rate of 1.2ml/min and the following gradient elution: MeCN 0.1%
AcOH (B)/H2O(A) 0.1% AcOH; 0–35min 0–25% B (linear gradi-
ent), 35–60min 25% B (isocratic), 5min 100% B. The samples were
solubilized in 1:1 A/B to give a concentration of 2mg/ml then ﬁl-
tered through a 0.45m PTFE membrane (Millipore). The volume
injectedwas 20l. TheUV-DADdetectorwas set to record between
210 and 600nm, andUV chromatogramswere recorded at 215, 254
and 325nm.
The quantiﬁcation was carried out using analytical curves plot-
ted with data of standard compounds which were previously
isolated in our laboratory. These compounds were solubilised in
a stock solution of 1:1 MeCN–H2O containing ﬂavone as inter-
nal standard. The analyses were carried out in duplicate and in
serial concentrations: tagitinin C from 2000 to 1g/mL, 5-O-(E)-
caffeoylquinic acid from500 to0.25g/mLand luteolin from250 to
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.5g/mL. The standard compounds comprise a STL, a chlorogenic
cid (CA) and a ﬂavone, respectively. Tagitinin C and luteolin were
nalysed at 254nm and 5-O-(E)-caffeoylquinic acid at 325nm. The
hromatographic conditions are the same described in the para-
raph above.
.4. Animals
Male BALB/c mice, 25–30g, were obtained from the animal
acilities of the FCFRP, USP, Ribeirão Preto, SP, Brazil, and main-
ained under standard laboratory conditions (21–24 ◦C at 40–60%
elative humidity on a 12h light-dark cycle). The experiments
ere approved by the Institutional Ethical Animal Committee of
he Universidade de São Paulo (protocol number 08.1.464.53.7),
hich followed the rules of the Brazilian Committee to Animal Care
COBEA).
.5. In vivo anti-inﬂammatory assays
.5.1. Mice paw oedema
The previously described method of carrageenan-induced paw
edema in mice (Winter et al., 1962) was used in this work. Paw
edema was induced in the hind paws of mice by the intraplan-
ar injection of 50L of lambda carrageenan (Sigma–Aldrich), 1%
/v in phosphate buffered saline (PBS). The contralateral paw
as used as a control, being injected with the same volume of
he vehicle (PBS). The course of the oedema was monitored by
easuring the thickness of footpad swelling at 0, 1, 2, 3, 4, 5
nd 6h after carrageenan injection using a dial thickness gauge
alliper Mitutoyo (Kawasaki). Animals (n=6) received either vehi-
le (control animals), or extracts at concentrations of 10, 50, 100
r 150mg/kg, p.o., 30min before the carrageenan administration.
tube-feeding was used as p.o. administration and the vol-
me administrated was 10mL/kg. Indomethacin (Sigma–Aldrich),
0mg/kg, was used as the positive control. The vehicle for PE, infu-
ion and indomethacin was distilled water, and for LRE it was
omposed of 10% Cremophor® EL in distilled water. The differ-
nt vehicles did not differ signiﬁcantly in their effects; in order to
implify, only one of them is shown here. The assay was double-
linded andalways initiated in the sameperiodof theday (between
:00 am and 12:00 pm) to avoid interference with circadian vari-
tion in the level of corticosteroids (Soliman et al., 1983). The
ata were expressed as mean± SEM and analysed by two-way
NOVAfollowing theapplicationofBonferroni’s test. The inhibition
ercentages were calculated according to the following formula:
(mean of values of negative control group−mean of values of
reated group)/mean of values of negative control group]×100.
.5.2. Croton oil ear oedema
The previously described method of the croton oil ear oedema
ssay inmice (Tubaroet al., 1985)wasused in thisworkwithgroups
f eight animals. The extracts (0.05, 0.5, 1, 2 and 3mg/ear) and
ehicle (control animals) were applied topically 30min after the
pplication of 20l croton oil (Sigma–Aldrich), 5% v/v in acetone,
n the inner surface of each left ear. Indomethacin (0.45mg/ear)
as used as positive control. The vehicle for PE, indomethacin and
nfusion was 20% distilled water in glycerine; for LRE it was 20%
cetone in glycerine. The different vehicles did not differ signiﬁ-
antly in their effects and only one is shown here. The oedema was
easured 6h after starting the experiment as the weight differ-
nce between 6mm plugs taken from the left and right ears. The
ssay was double-blinded and always initiated at the same time
f day, as in the above experiment (Section 2.5.1). The data were
xpressed asmean± SEMand analysed by one-wayANOVA follow-
ng the use of Dunnett’s multiple comparison test. The inhibitionpharmacology 136 (2011) 355–362 357
percentages were calculated according to the same formula given
in the previous section.
2.5.3. Measurement of neutrophil migration
The plugs of the left ears obtained in the assay described above
(Section 2.5.2) were kept in 200l of NaEDTA/NaCl buffer (pH 4.7)
at −20 ◦C until analysis. Samples were homogenised using a Poly-
tron homogeniser (13,000 rpm, 3×), and centrifuged at 10,000× g
for 15min, at 4 ◦C. The pellet was re-suspended in 200l 0.5%
hexadecyltrimethyl ammoniumbromide (Sigma–Aldrich) in buffer
at pH 5.4, and homogenised one more time. The samples were
re-centrifuged and 20L of the supernatant was used to mea-
suremyeloperoxidase (MPO) activity. The 20L samplewasmixed
with 30l of 0.08M NaPO4. The enzymatic reaction was car-
ried out with 50L of substrate reagent (tetramethylbenzidine
and hydrogen peroxide; BD-OptEIATM). After 10min the reaction
was stopped with 2.5M H2SO4. The absorbance was measured at
450nm, and the results were expressed as MPO activity (number
of neutrophils 104/ear). The mean± SEM was analysed by one-way
ANOVA following Dunnett’s multiple comparison test. The inhibi-
tion percentages were calculated according to the same formula
given in the previous sections.
3. Results
3.1. Phytochemical analysis and quantiﬁcation of the major
compounds
The way the extracts were prepared fulﬁlled the objective of
obtaining one extract rich in STLs, another lacking this class of com-
pounds and a third containing polar compounds as well as STLs.
The LRE is rich in STLs, as shown by the typically strong band
of carbonyl stretching of the -lactones at 1760 cm−1 in the IR
spectrum and UV absorption between 210 and 220nm in the UV
spectrum from the HPLC-UV-DAD analysis (Figs. 1–3; Fischer et al.,
1979; Ambrosio et al., 2008). Moreover, the quantiﬁcation proce-
dure showed 479.39g of tagitinin C (peak 5, Fig. 3) per milligram
of LRE (y=0.0148x+0.0636, r2 =0.9999). Some STLs, such as tag-
itinin C, show UV absorption around 250nm because of the two
conjugation extensions in the 10-membered ring. Some ﬂavonoids
are also present in the LRE (peaks 1, 3, 4 and 6—Fig. 3), as shown by
their typicalUVspectra (AndersenandMarkhan,2006;Gobbo-Neto
and Lopes, 2008) as well as the quantiﬁcation procedure: 5.10g
of luteolin (peak 3) per milligram of LRE (y=0.0298x+0.0726,
r2 =0.9974).
Conversely, the PE lacked STLs, or their quantities were unde-
tectable in both the IR and HPLC-UV-DAD analysis (Figs. 1–3). This
extract has polar compounds (39.08g of 5-O-(E)-caffeoylquinic
acid – peak 7 – per milligram of PE; y=0.0608x−0.2887,
r2 =0.9961) whose peaks appear in the beginning of the chro-
matogram until 30min, with UV spectra characteristic of CAs
(UVmax at approximately 298 and 325nm; Gobbo-Neto and Lopes,
2008).
The infusionhasachemicalproﬁlevery similar to thePE (8.02g
of 5-O-(E)-caffeoylquinic acid per milligram of infusion), except for
thepresence of STLs at very lowconcentrations (3.13g of tagitinin
C per milligram of infusion, Fig. 2C and D), which can be observed
by the low-intensity peaks on the chromatogram (Fig. 3). Curiously,
the IR spectrum of the infusion did not show the typical carbonyl-
associated bands at 1760 cm−1 (Fig. 1).
3.2. In vivo anti-inﬂammatory assays3.2.1. Mice Paw oedema
In carrageenan-induced mice paw oedema, the LRE and PE,
whose chemical constitutions are quite different (Fig. 2B and D),
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howed signiﬁcant anti-oedematogenic activity (p.o.) at all tested
oses (Fig. 4). The effect of the reference drug (indomethacin) and
he LRE began in the third hour after treatment and remained
hroughout the experiment. Interestingly, the PE, at doses of 10
nd 50mg/kg (mean inhibition of 64.3 and 66.4%, respectively),
howedahigher anti-oedematogenic effect than the referencedrug
nd LRE (mean inhibition of 45.4% and 52.1%, respectively). More-
ig. 2. 3D chromatograms of the mobile phase—MeCN:H2O (A), LRE (B), PE (C), and infu
eries (3mm×100mm); 1.2ml/min; 0–25% MeCN in 30min, 25% MeCN isocratic until 60 
e typical strong band of carbonyl stretching of -lactone at 1760 cm−1.
over, the activity of PE at doses of 50 and 100mg/kg began in the
ﬁrst hour, before the indomethacin and LRE, which began show-
ing effects only in the third hour. In contrast, the infusion, which
is chemically similar to the PE (Fig. 2C and D), showed very dif-
ferent outcomes because all tested doses showed no signiﬁcant
anti-oedematogenic activity. A very low activity could be observed
only at the largest doses (100 and 150mg/kg; mean inhibition
sion (D) obtained by HPLC-UV-DAD using two coupled C18 monolithic columns in
min and 100% MeCN for 5min; 0.2% AcOH.
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Fig. 3. Chromatograms recorded at 215, 254 and 325nm of the mobile phase and t
wo coupled C18 monolithic columns in series (3mm×100mm); 1.2ml/min; 0–2
cOH. Intense peaks 2 and 5 are sesquiterpene lactones; weak peaks 1, 3, 4 and 6 a
f 19.6 and 35.5%, respectively) in the sixth hour after treatment
Fig. 4).
.2.2. Croton oil ear oedema
The PE showed signiﬁcant anti-oedematogenic activity at all
ested doses, when applied topically (Fig. 5, mean inhibition of
6.6%). The infusion did not show signiﬁcant activity in dimin-
shing croton oil-induced oedema at any tested dose, even though
ts activity was intermediary (mean inhibition of 16.0%) between
he negative (vehicle) and positive (indomethacin;mean inhibition
f 29.9%) control groups. The LRE, rich in STLs, demonstrated sig-
iﬁcant effect only at the largest doses (1, 2 and 3mg/ear; mean
nhibition of 28.2%); doses of 0.05 and 0.5mg/ear showed only
ntermediary effect (mean inhibition of 16.2%).
.2.3. Measurement of neutrophil migration
Reference drug andnegative control groupswere similarly inac-
ive at inhibiting neutrophil migration (Fig. 6). Interestingly, for
ll extracts, including the infusion, the lowest doses (0.05 and
.5mg/ear)were signiﬁcantlymore active for inhibiting neutrophil
igration (mean inhibition of 86.5, 83.1 and 79.7% for LRE, PE and
nfusion, respectively), while the highest doses (1, 2 and 3mg/ear)
id not signiﬁcantly affect neutrophil recruitment to the site of
nﬂammation (Fig. 6). The LRE at 3mg/ear showed some, but not
igniﬁcant, inhibition of MPO activity (mean inhibition of 41.7%;
ig. 6).xtracts (LRE, PE and infusion). The proﬁles were obtained by HPLC-UV-DAD using
CN over 30min, 25% MeCN isocratic until 60min and 100% MeCN for 5min; 0.2%
onoids; peak 7 is chlorogenic acid.
4. Discussion
Obtaining three chemically different extracts from the leaves of
T. diversifolia was successful (Figs. 1–3) and allowed us to evalu-
ate the contribution of different classes of secondary metabolites
to the observed anti-inﬂammatory activity and gain insights into
their mechanisms of action. The pharmacological effect of STLs and
ﬂavonoids could be evaluated by studying the LRE, while the effect
of CAs was discovered by analysing the PE. Moreover, the effect of
the infusion could also be evaluated.
In this study, it was observed that the PE and LRE, when topi-
cally applied, inhibited oedema (Fig. 5) and neutrophil migration
(Fig. 6). These extracts possibly act by similar way to the inhibition
of COX by NSAIDs. Additionally, they inhibit neutrophil migration,
mechanisms that NSAIDs do not display (Ferreira and Vane, 1974;
Parente, 2001). Therefore, the PE and LRE have better mechanisms
of action than NSAIDs.
When applied topically, PE at the lowest doses (0.05 and
0.5mg/ear) showed both mechanisms of action simultaneously
(inhibition of oedema and neutrophil migration; Figs. 5 and 6).
The anti-inﬂammatory effect of LRE and indomethacin was out-
performed by the PE due to another reason: the PE p.o. at the
lowest doses appeared to act by an additional mechanism of
action. The oral anti-oedematogenic effect was observed in the
ﬁrst hour, i.e., before the effect of LRE and indomethacin began in
the third hour, and remained constant during the entire experi-
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ndomethacin group (two-way ANOVA following the Bonferroni’s test).tion, the doses of 10 and 50mg/kg were more anti-oedematogenic
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the most potent NSAIDs in clinical use (Ferreira and Vane,
1974).
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The previously reported anti-inﬂammatory effects of some pure
As (Huang et al., 1991; Santos et al., 2006) are modest when com-
ared with our present results. Thus, the PE from the leaves of T.
iversifolia seems to be an efﬁcient pool of anti-inﬂammatory CAs
hat may act synergistically. Another important issue is that the
nly apparent difference between the chemical compositions of the
E and the infusion is the presence of STLs at low concentrations
n the infusion (Figs. 1–3). We do not believe that this difference is
nough to justify the absence of anti-oedematogenic activity of the
nfusion comparedwith that of PE (Figs. 4–6). Owoyele et al. (2004)
howed a signiﬁcant anti-odematogenic activity for the methano-
ic extract of T. diversifolia, which theoretically would have similar
omposition to the infusion evaluated in this study (CAs and some
TLs). Thus, we suggest the occurrence of antagonist compounds
nly in the infusion,which are probably produced or extracted dur-
ng the preparation process (hot water). However, infuse inhibit
eutrophil recruitment, so it can be useful for treatment of inﬂam-
atory process that present high cell inﬁltration and oedema is
ot involved (Witko-Sarsat et al., 2000; Castelucci et al., 2007;
enkatesha et al., 2011). In fact, the results justify the use of T.
iversifolia in traditional medicine.
Studying the anti-inﬂammatory effect of CAs, the main con-
tituents of PE, is justiﬁed because CAs are ubiquitous in the plant
ig. 6. Topical effect of LRE, PE and infusion on neutrophil recruitment to the inﬂamma
edema assay. Reference drug and negative control groups were not signiﬁcantly differen
n=5). *P<0.05 when compared to controls groups (one-way ANOVA following the Dunna assay. The values represent the mean± SEM (n=8). *P<0.05 when compared to
p (one-way ANOVA following the Dunnett’s multiple comparison test).
kingdom, and there is evidence suggesting that the consump-
tion of food rich in these compounds reduces the incidence of
cancer, coronary heart disease and inﬂammatory diseases (Zhao
and Moghadasian, 2010). As anti-inﬂammatory compounds like
CAs are found in several plants, Calixto et al. (2004) suggested
that even plants that are not used in folk medicine could present
anti-inﬂammatory properties. However, the difference between
results of infusion and PE (rich in such ubiquitous compounds),
indicate that although the majority of plants could present anti-
inﬂammatory activities, to have or not such activity or the category
of anti-inﬂammatory effect depends on a lack of antagonist com-
pounds that can be correlated with the extraction method.
Finally, it is important to mention that some side effects of
NSAIDs, as gastric damage, are associated the high neutrophil inﬁl-
tration (Ferreira and Vane, 1974; Parente, 2001); thus, PE and
LRE can inhibit oedema and neutrophil recruitment concomitantly
and possible does not display this kind of side effect. Addition-
ally, some studies attributed a protective effect on gastric mucosa
to STLs (Giordano et al., 1992; Heinrich et al., 1998), which is
very important given the concern about the gastric damage dis-
played by NSAIDs is taken into account. One piece of evidence
corroborating this statement is the fact that budlein A, a promising
anti-inﬂammatory LST, did not show gastric damage and therefore
tory site. The measurements were on ear plugs obtained from the croton oil ear
t, and neither inhibited neutrophil migration. The values represent the mean± SEM
ett’s multiple comparison test).
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ay be useful for at least short-term therapies without the side
ffects displayed by known drugs (Valério et al., 2007). In sum-
ary, based on our results, the potential of CAs or STLs as oral and
opic anti-inﬂammatory drugs is evident.
. Conclusions
The STLs are not the only anti-inﬂammatory class of compounds
rom T. diversifolia. CAs also showed strong oral and topical activ-
ty in our models. The PE, rich in CAs, showed better results than
ndomethacin, one of the most potent NSAIDs, the STL-rich LRE
nd other CAs reported in the literature. The three extracts of T.
iversifolia, including the infusion, seem to act by dose-dependent
echanisms that are different from the mechanisms of action of
SAIDs and can therefore be useful as alternative treatments for
nﬂammatory diseases.
We also conclude that the mode of extract preparation also
xerts inﬂuence on the activity; the infusion, which is chemically
imilar to the PE, showed different anti-inﬂammatory effect. This
bservation suggests that even though themajority of plant species
ave CAs, their anti-inﬂammatory effects will depend upon the
bsence, or at least on a low amount, of antagonist compounds.
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Glossary
CA: chlorogenic acids
COX: cyclooxygenase
IR: infrared
LOX: lipoxygenase
LRE: leaf rinse extract
MPO: myeloperoxidasePE: polar extracts from the rinsed leaves
STL(s): sesquiterpene lactone(s)
